Leiden University Scholarly Publications

Your Search

Enabled Filters

  • (-) = Leebeek, F.W.G.

Refine Results

Resource Type

Availability

Creation Date

Show more

Author

Show more

Language

Search results

  • RSS Feed
(61 - 80 of 100)

Pages

Monitoring of treatment with vitamin K antagonists: recombinant thromboplastins are more sensitive to factor VII than tissue-extract thromboplastins
Can we prevent venous thrombosis with statins: an epidemiologic review into mechanism and clinical utility
Von Willebrand's Disease
Control of anticoagulation with vitamin K antagonists: overestimation of median time in therapeutic range when assessed by linear interpolation
Genome-wide association studies identify genetic loci for low von Willebrand factor levels
Impact of point-of-care international normalized ratio monitoring on quality of treatment with vitamin K antagonists in non-self-monitoring patients: a cohort study
Perioperative treatment of hemophilia A patients: blood group O patients are at risk of bleeding complications
Joint surgery in von Willebrand disease: a multicentre cross-sectional study
Bleeding spectrum in children with moderate or severe von Willebrand disease: Relevance of pediatric-specific bleeding
Agreement between Coaguchek XS and STA-R Evolution (Hepato Quick) INR results depends on the level of INR
The "OPTI-CLOT" trial
Plasma ADAMTS-13 levels and the risk of myocardial infarction: an individual patient data meta-analysis
Primary postpartum haemorrhage in women with von Willebrand disease or carriership of haemophilia despite specialised care: a retrospective survey
CLEC4M and STXBP5 gene variations contribute to vonWillebrand factor level variation in von Willebrand disease
Joint bleeds in von Willebrand disease patients have significant impact on quality of life and joint integrity: a cross-sectional study
von Willebrand factor propeptide and the phenotypic classification of von Willebrand disease
von Willebrand disease and aging: an evolving phenotype
Inhibitors increase the burden of disease in nonsevere haemophilia A patients - treatment strategies to obtain hemostasis
Prediction of DDAVP response in 850 non-severe hemophilia A patients
Von Willebrand Factor antigen and age explain variation in baseline FVIII:C among nonsevere hemophilia A patients with the same F8 genotype (Arg593Cys and Asn618Ser)

Pages